Skip to main content

Table 2 Patients Characteristics

From: Multicenter safety study of mFOLFOX6 for unresectable advanced/recurrent colorectal cancer in elderly patients

  < 70 Years (n = 14) ≥ 70 Years (n = 8) P values
Age (median) 63.5 [39–69] 74.5 [71–79] -
Sex (male/female) 11/3 5/3 *0.3695
PS (ECOG) 0/1/2 9/5/0 7/1/0 **0.2505
Primary tumor Colon/rectum/colorectal 4/8/2 7/1/0 *0.011/0.052/0.3939
Target lesions
liver/lung/LN/peritoneum/others
4/2/6/0/2 4/1/1/1/1 *0.291/0.709/0.161/
0.364/0.709
Previous surgery (+/-) 12/2 8/0 *0.3939
Adjuvant chemotherapy(+/-) 4/10 2/6 *0.6305
Previous treatment (+/-) 1/13 1/7 *0.6060
  1. Abbreviation: PS, performance status; ECOG, Eastern Cooperative Oncology Group; LN, lymph node.
  2. *P values for SEX, primary tumor, target lesions, previous surgery (+/-), adjuvant chemotherapy (+/-) and previous treatment (+/-) were calculated with the use of Fisher's exact probability test. **P values for PS were calculated with the use of Mann-Whitney U test.